ORI Capital is a venture capital firm founded in 2015 which invests in innovative early-stage biotech companies globally. Our mission is to be both financially successful for our investors and socially impactful to patients worldwide.
An Introduction to ORI Capital
We invest in the most promising innovations and disruptive technologies in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases.
HKFSDC Hong Kong Success Stories Series - Hi Beautiful Minds (ORI Capital)
Simone Song, Founder of ORI Capital shares with Laurence Li, Chairman of FSDC her beautiful evolution from tumor battling to carrying out investment for saving lives, with scientific inspiration and the help of both Artificial and Human Intelligence.